ID

34481

Description

SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055

Lien

https://clinicaltrials.gov/show/NCT01953055

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 22/05/2019 22/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01953055

Eligibility Prostate Cancer NCT01953055

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained
Description

ID.1

Type de données

boolean

men > 18 years of age
Description

ID.2

Type de données

boolean

histologically confirmed prostate adenocarcinoma (centrally reviewed)
Description

ID.3

Type de données

boolean

high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Description

ID.5

Type de données

boolean

anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Description

ID.6

Type de données

boolean

diagnosis of bleeding diathesis
Description

ID.7

Type de données

boolean

large prostate (>90cm3) on imaging at time of gold seed insertion
Description

ID.8

Type de données

boolean

no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
Description

ID.9

Type de données

boolean

definitive regional or distant metastatic disease on staging investigations
Description

ID.10

Type de données

boolean

Similar models

Eligibility Prostate Cancer NCT01953055

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained
boolean
ID.2
Item
men > 18 years of age
boolean
ID.3
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
ID.4
Item
high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
prior pelvic radiotherapy
boolean
ID.6
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
ID.7
Item
diagnosis of bleeding diathesis
boolean
ID.8
Item
large prostate (>90cm3) on imaging at time of gold seed insertion
boolean
ID.9
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
boolean
ID.10
Item
definitive regional or distant metastatic disease on staging investigations
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial